Sterling Biotech Ltd.

BSE: 512299
₹0.77
▼ -0.04 (-4.94%)
Nov. 5, 2018 · BSE · bse_bhavcopy
Quality
—/100
Data unavailable
Valuation
—/100
Data unavailable
Momentum
42/100
Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
Data unavailable.
PE (TTM)
Data unavailable.
Price to Book
Data unavailable.
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
22.33%
FII + DII, latest filed period
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
4.2
Relative return vs Sector, qtr %
Data unavailable.
Free Cash Flow
Data unavailable.
EPS Growth (YoY)
Data unavailable.
Net Profit Growth (TTM)
Data unavailable.
Operating Revenue Growth (TTM)
Data unavailable.
Profit Growth (YoY)
Data unavailable.
Revenue Growth (YoY)
Data unavailable.
Current Ratio
Data unavailable (needs a filed half-yearly balance sheet).
Debt to Equity
Data unavailable (needs a filed half-yearly balance sheet).
Interest Coverage
Data unavailable.
Net Margin
Data unavailable.
Operating Margin (EBIT)
Data unavailable.
Operating Margin (TTM)
Data unavailable.
Return on Assets
Data unavailable.
Return on Capital Employed
Data unavailable (needs a filed half-yearly balance sheet).
Return on Equity
Data unavailable (needs a filed half-yearly balance sheet).

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Ownership

2 of 2 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter

Value and momentum

0 of 4 met
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-4.9%
Low 0.7700 · High 0.8500
1W return
-4.9%
Low 0.7700 · High 0.8500
1M return
10.0%
Low 0.6700 · High 0.8500
52W return
-78.6%
Low 0.6700 · High 5.5900
Lifetime High ₹250.4000 (July 30, 2008)
Lifetime Low ₹0.7000 (Oct. 1, 2018)

Full price history and technicals →

EMA & SMA

Bullish0
Bearish6
5D
0.8
10D
0.8
20D
0.9
50D
1.5
100D
2.1
200D
3.1

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
100.0%
Month avg. delivery
100.0%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

0.80
Pivot
First resistance0.82
Second resistance0.88
Third resistance0.90
First support0.74
Second support0.72
Third support0.66
Day RSI24.7
Day MFI32.3
Day MACD-0.21
Day MACD signal-0.25

Beta

1M—
3M—
1Y0.69
3Y1.16

Price change analysis

↑ 10.0%
Over 1 Month
LowHigh
0.670.85
↓ -15.4%
Over 3 Months
LowHigh
0.670.95
↓ -53.9%
Over 6 Months
LowHigh
0.671.61
↓ -78.6%
Over 1 Year
LowHigh
0.675.59
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Data unavailable.

Shareholding pattern / Ownership

Shareholding summary

Sep 2022
  • Promoter24.64%
  • FII/FPI21.93%
  • Public53.03%

Largest holders

NameCategoryShares %Shares
Foreign BankPublic9.2700%25226463
The Bank Of New YorkPublic9.2700%25226463
Albula Investment Fund LtdPublic5.2500%14285273
Foreign Institutional InvestorsPublic5.1200%13948302
Lotus Global Investments Ltd-Adr/GdrPublic5.1200%13948302

As of Sept. 30, 2022. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 24.64% in Sep 2022 qtr

Historical fii holding

FII/FPI holdings increased from 12.66% to 21.93% in Sep 2022 qtr

All shareholding details →

DateClientDealActionQuantityPriceExchange
14 Feb 2012 DAIWA CAPITAL MARKETS SINGAPORE LIMITED Block Sell 1,800,000 13.6500 BSE
14 Feb 2012 AVATAR INDIA OPPORTUNITIES FUND Block Buy 1,800,000 13.6500 BSE
14 Feb 2012 AVATAR INDIA OPPORTUNITIES FUND Bulk Buy 1,800,000 13.6500 BSE
14 Feb 2012 DAIWA CAPITAL MARKETS SINGAPORE LIMITED Bulk Sell 1,800,000 13.6500 BSE
20 Jan 2012 BP FINTRADE PRIVATE LIMITED Bulk Sell 1,752,713 12.8500 BSE
18 Jan 2012 Naman Securities & Finance Pvt. Ltd. Bulk Sell 1,384,618 11.6700 BSE
18 Jan 2012 Naman Securities & Finance Pvt. Ltd. Bulk Buy 1,499,476 11.6100 BSE
18 Jan 2012 VISHESH CAPITAL PVT LTD Bulk Buy 1,515,687 11.6600 BSE
18 Jan 2012 VISHESH CAPITAL PVT LTD Bulk Sell 1,515,687 11.3900 BSE
18 Jan 2012 MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED Bulk Sell 1,650,038 11.7300 BSE

All bulk and block deals →

Ex-dateSubjectPer share (₹)Record date
21 Jun 2011 Annual General Meeting And Dividend Re.0.50 Per Share 0.5000 —
21 Jun 2010 Dividend-Re.0.50 Per Share 0.5000 —
22 May 2008 Agm/Dividend - 50% — —
15 Jun 2006 Dividend-50% — —

Corporate Actions

Full history (13 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from Sterling Tea & Industries Ltd to Sterling Biotech Ltd.
21 Sep 2017OTHER Annual General Meeting
21 Sep 2016OTHER Annual General Meeting
19 Jun 2015OTHERAnnual General Meeting
20 Jun 2014OTHERAnnual General Meeting

All corporate actions →

Corporate Announcements

All 192 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
24 Feb 2023 Delisting Members of the Exchange are hereby informed that the admission to dealings in securities of the company Sterling Biotech Limited shall be withdrawn (delisted) w.e.f. March 03, 2023 pursuant to Hon ble National Company Law Tribunal (NCLT) order dated November 11, 2022.
15 Nov 2022 Liquidation Sterling Biotech Limited has informed the Exchange about Liquidation process
24 Apr 2022 Liquidation Sterling Biotech Limited has informed the Exchange about Liquidation
21 Jan 2022 Corporate Insolvency Resolution Process Sterling Biotech Limited has informed the Exchange about Corporate Insolvency Resolution Process
25 Oct 2021 Corporate Insolvency Resolution Process Please find attached herewith Audited Financial Statement for the financial year 2020-21 of Sterling Biotech Limited along with Auditors Report.
21 Oct 2021 Corporate Insolvency Resolution Process Sterling Biotech Limited has informed the Exchange about Corporate Insolvency Resolution Process
21 Jul 2021 Corporate Insolvency Resolution Process Non Applicability Certificate Corporate Governance June 2021
7 Jul 2021 Corporate Insolvency Resolution Process Please find attached herewith Audited Financial Statement for the financial year 2019-20 of Sterling Biotech Limited along with Auditors Report.
16 Jun 2021 Corporate Insolvency Resolution Process Please find attached herewith Audited Financial Statement for the financial year 2018-19 of Sterling Biotech Limited duly signed by Mr. Sundaresh Bhat (Erstwhile Resolution Professional) dated 18.02.2021 along with Auditors' Report.
2 Mar 2021 Corporate Insolvency Resolution Process Intimation of Public Announcement for seeking claim (Intimation under Regulation 30 of SEBI (LODR),2015)

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

Data unavailable.

Opportunities

  • RSI in oversold territory (24.7) -- a technical rebound zone

Threats

  • Down 78.6% over the past year

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Sterling Biotech Ltd.

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.